This inventor holds 5 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignee: Als Therapy Development Institute. Active years: 2018-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2018-2025
Title: The Innovative Contributions of Bingbing Jiang
Introduction
Bingbing Jiang is a prominent inventor based in Brighton, MA (US), known for her significant contributions to the field of biotechnology. With a total of five patents to her name, she has made remarkable strides in developing therapies for CD40L-related diseases.
Latest Patents
Among her latest patents are the "Anti-CD40L antibodies and methods for treating CD40L-related diseases or disorders." These innovative anti-human CD40L antibodies are engineered to lack the ability to activate platelets, providing new methods for treating patients suffering from CD40L-associated diseases. This groundbreaking work showcases her commitment to advancing medical science and improving patient outcomes.
Career Highlights
Bingbing Jiang currently works at the ALS Therapy Development Institute, where she continues to push the boundaries of research and innovation. Her work is instrumental in developing therapies that address critical health challenges.
Collaborations
Bingbing has collaborated with notable colleagues, including John Monteith Lincecum and Steven N Perrin, further enhancing the impact of her research through teamwork and shared expertise.
Conclusion
Bingbing Jiang's contributions to biotechnology and her innovative patents reflect her dedication to improving healthcare solutions. Her work continues to inspire advancements in the treatment of complex diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile